Reports for SANDOZ CANADA INCORPORATED

Company Name

SANDOZ CANADA INCORPORATED

Totals

Shortage reports

2123

Actual shortage: 50 (2%)
Anticipated shortage: 9 (0%)
Avoided shortage: 19 (1%)
Resolved: 2045 (96%)

Discontinuation Reports

101

To be discontinued: 1 (1%)
Discontinued: 98 (97%)
Reversed: 2 (2%)

Late reports

444 (20%)

Overdue reports

38 (63%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
SANDOZ ATORVASTATIN 10MG TABLET Resolved 2019-11-20 2020-01-22 99333
SANDOZ ATORVASTATIN 10MG TABLET Resolved 2023-11-22 2024-02-27 211127
SANDOZ ATORVASTATIN 40MG TABLET Resolved 2023-12-11 2024-01-03 213002
SANDOZ ATORVASTATIN 40MG TABLET Resolved 2023-12-11 2024-02-20 213005
SANDOZ ATORVASTATIN 20MG TABLET Resolved 2023-12-19 2024-01-03 213794
SANDOZ ATORVASTATIN 80MG TABLET Resolved 2023-12-19 2024-01-24 213798
SANDOZ ATORVASTATIN 10MG TABLET Resolved 2024-01-03 2024-03-12 214771
SANDOZ AZITHROMYCIN 200MG POWDER FOR SUSPENSION Resolved 2023-05-25 2023-07-11 193041
SANDOZ AZITHROMYCIN 100MG POWDER FOR SUSPENSION Resolved 2023-06-12 2023-07-11 194749
SANDOZ AZITHROMYCIN 200MG POWDER FOR SUSPENSION Resolved 2025-02-17 2025-04-23 250512
SANDOZ AZITHROMYCIN 250MG TABLET Actual shortage 2025-02-24 2025-05-12 251110
SANDOZ AZITHROMYCIN 200MG POWDER FOR SUSPENSION Resolved 2022-11-16 2022-11-29 174963
SANDOZ AZITHROMYCIN 200MG POWDER FOR SUSPENSION Resolved 2022-11-28 2023-01-19 175980
SANDOZ AZITHROMYCIN 200MG POWDER FOR SUSPENSION Resolved 2023-01-19 2023-02-01 181665
SANDOZ AZITHROMYCIN 200MG POWDER FOR SUSPENSION Resolved 2023-02-09 2023-03-02 184233
SANDOZ AZITHROMYCIN 200MG POWDER FOR SUSPENSION Resolved 2023-04-21 2023-07-05 190134
SANDOZ AZITHROMYCIN 200MG POWDER FOR SUSPENSION Resolved 2023-04-21 2023-07-11 190138
SANDOZ AZITHROMYCIN 200MG POWDER FOR SUSPENSION Resolved 2019-09-10 2019-09-25 93361
SANDOZ AZITHROMYCIN 200MG POWDER FOR SUSPENSION Resolved 2020-02-03 2020-02-15 105200
SANDOZ AZITHROMYCIN 200MG POWDER FOR SUSPENSION Resolved 2020-04-21 2020-05-19 112668

Showing 661 to 680 of 2123

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ALFENTANIL INJECTION USP Discontinued 2019-10-15 2019-10-15 96610
ATRACURIUM BESYLATE INJECTION Discontinued 2019-10-15 2019-10-15 96613
BETAJECT Discontinued 2019-10-15 2019-10-15 96616
BLUE COLLYRIUM Discontinued 2019-10-15 2019-10-15 96619
BRETYLIUM TOSYLATE INJECTION USP Discontinued 2020-04-01 2020-04-01 110288
BRETYLIUM TOSYLATE INJECTION USP 50MG SOLUTION Discontinued 2017-12-06 2017-12-06 31958
CLINDAMYCIN INJECTION USP 150MG LIQUID Discontinued 2017-06-06 2017-10-18 12122
CODEINE PHOSPHATE INJECTION USP 30MG LIQUID Discontinued 2022-04-20 2022-04-20 159064
COMTAN 200MG TABLET Discontinued 2022-03-03 2022-03-04 155940
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Discontinued 2018-08-27 2019-01-02 59179
FOLIC ACID INJECTION USP 5MG LIQUID To be discontinued 2019-05-01 2019-05-01 82956
FOLIC ACID INJECTION USP 5MG LIQUID Discontinued 2020-01-28 2020-01-28 104481
HEPARIN SODIUM INJECTION USP (SINGLE USE VIAL-PRESERVATIVE FREE) 10000UNIT SOLUTION Discontinued 2018-07-04 2018-07-31 54349
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2024-05-17 2024-05-18 228249
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2023-10-18 2023-10-19 207275
IMIPENEM AND CILASTATIN FOR INJECTION USP 250MG 250MG POWDER FOR SOLUTION Discontinued 2021-08-23 2021-08-23 144467
LORAZEPAM INJECTION USP 2MG SOLUTION Discontinued 2020-02-14 2020-03-12 106265
MICRO PLUS 6 (CONCENTRATE) 75MCG 60MCG 10MCG 0.5MG 1MG 5MG LIQUID Discontinued 2021-10-25 2021-10-26 147927
MILRINONE LACTATE INJECTION 1MG SOLUTION Discontinued 2022-06-17 2022-06-18 163000
OLANZAPINE FOR INJECTION 10MG POWDER FOR SOLUTION Discontinued 2020-06-22 2020-06-22 118553

Showing 1 to 20 of 101